Pomalyst and Cosopt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pomalyst (pomalidomide) and Cosopt (dorzolamide hydrochloride; timolol maleate). Common drug interactions include back pain among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Pomalyst and Cosopt. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.

On Jul, 06, 2026

19 people who take Pomalyst and Cosopt together, and have interactions are studied.

What are the common drug interactions of Pomalyst and Cosopt, by gender? *:

female:

Back pain
Localised infection (infection at the single location)
Constipation
Diarrhoea
Fatigue (feeling of tiredness)
Dyspepsia (indigestion)
Arthralgia (joint pain)
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Dyspnoea (difficult or laboured respiration)

male:

Pneumonia
Neutropenia (an abnormally low number of neutrophils)
Decreased appetite
Dysgeusia (disorder of the sense of taste)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Memory impairment
Muscular weakness (muscle weakness)
Plasma cell myeloma (cancer that begins in plasma cells)
Viral infection
Fatigue (feeling of tiredness)

What are the common drug interactions of Pomalyst and Cosopt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Neutropenia (an abnormally low number of neutrophils)
Pneumonia
Muscular weakness (muscle weakness)
Nasopharyngitis (inflammation of the nasopharynx)
Night sweats (sweating in night)
Peripheral coldness
Plasma cell myeloma (cancer that begins in plasma cells)
Rhinorrhoea (watery mucus discharge from the nose)
Tooth infection
Viral infection

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 100.00%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Eye Disorder: 2 people, 10.53%
Urinary Bladder Haemorrhage (urinary bladder bleeding): 1 person, 5.26%
Prostatomegaly (enlargement of the prostate): 1 person, 5.26%
Nausea And Vomiting: 1 person, 5.26%
Itching: 1 person, 5.26%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Cardiac Failure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalyst and Cosopt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously